TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Degree of satisfaction regarding the learning method
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Likelihood to recommend the course to a colleague
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: cumulative IBE incidence at five years post-surgery
Endpoint domain: Mortality/survival
Primary endpoint: pathological progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the mean number of hot flushes per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: substance-related outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intention to phone an ambulance for ACS symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Permanent pacemaker implantation at 30 days
Endpoint domain: Adverse events/effects
Primary endpoint: Aortic valve-related hospitalizations at 1 year
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: All-cause mortality at 30 days and 1 year
Endpoint domain: Mortality/survival
Primary endpoint: Urogenital Distress Inventory-6 score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incontinence Severity Index score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IgG anti-dsDNA antibody levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk for severe flare (BILAG-2004 grade A)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MADRS depression score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-rated memory
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: anterograde verbal memory
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Insulin Resistance (IR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Systolic Blood Pressure (BP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Diastolic Blood Pressure (BP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: HC-induced adverse mood symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: Cost-effective health care recommendations
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: IOL tilt orientation stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HADS-D scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Odds of receiving a prescription for opioid medication at ED discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AQLQ
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ACQ-7
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DHI total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Center of pressure velocity with eyes open
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Willingness to discuss trials
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: glycemic responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Paresthesia/dysesthesia pain character
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: all-cause mortality and HF hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: Monthly headache days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cognitive performance levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Intensity of early onset swelling
Endpoint domain: Adverse events/effects
Primary endpoint: Intensity of erythema
Endpoint domain: Adverse events/effects
Primary endpoint: Pain/tenderness
Endpoint domain: Adverse events/effects
Primary endpoint: Choice of intervention modules
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Public perceptions of rTMS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: worse functional outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: more serious adverse events (SAEs), particularly cardiac events
Endpoint domain: Adverse events/effects
Primary endpoint: Social development
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Negative conversion time of nucleic acid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Negative conversion rate of nucleic acid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative rate of HF hospitalisation
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of pulmonary complications (PPCs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Severity of pulmonary complications (PPCs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Post-prandial plasma glucose homoeostasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Oxyntomodulin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Diet adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gugging Swallowing Screen (GUSS) scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality associated with moderate to severe anaemia
Endpoint domain: Mortality/survival
Primary endpoint: first heart hospitalization (HHF) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cure rate of S. mansoni infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Prevalence of S. mansoni
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Inductions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Improvement in core symptoms of ASD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PaCO2 level within 24 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: PaO2/FIO2 ratio at 6 h, 12 h, and 24 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Teachers' retained knowledge on ADHD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Systolic daytime blood pressure variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of total OA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of knee OA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of hip OA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visceral trauma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge assessment scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cOR for primary outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean osteocalcin score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intention to commit violence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: agreement with any reason that justifies wife beating
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: quality of relationship
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cheek flexibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tongue protrusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in delay associated with the study intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Activity of ?‐amylase in saliva and urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Plaque removal rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of responders
Endpoint domain: Adverse events/effects
Primary endpoint: Perceived harm of smoking
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in nasal symptom score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MACE risk
Endpoint domain: Mortality/survival
Primary endpoint: KOOS symptoms score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: KOOS knee-related quality of life score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Reduction in pro-inflammatory biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NPRS (Numeric Pain Rating Scale)
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: fatal cardiovascular events
Endpoint domain: Adverse events/effects
Primary endpoint: Patient tolerability
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Attitudes Towards Older Adults Using Technology (ATOAUT)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Willingness to pay for hand surgery procedures
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Exercise capacity and endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Loads at failure of internal fixation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: oral pigmentation index scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total score of MiniBESTest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: no-CPR orders
Endpoint domain: Mortality/survival
Primary endpoint: decisional conflict knowledge subscale score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: peak oxygen uptake (VO2 peak) change after 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eye care utilization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to clinical response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary outcome event rate
Endpoint domain: Mortality/survival
Primary endpoint: postoperative comfort levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Malnutrition risk at discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nutritional treatment documentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nutritional care plan creation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SADL scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Heart failure events or cardiovascular death
Endpoint domain: Mortality/survival
Primary endpoint: Quick Disabilities of the Arm, Shoulder, and Hand scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physiological dead space rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: new clinical stroke
Endpoint domain: Mortality/survival
Primary endpoint: silent MRI infarct
Endpoint domain: Mortality/survival
Primary endpoint: TTI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BPI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: women's underweight prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: women's knowledge about appropriate age to introduce liquids
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to fusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative 6-month ODI
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Postoperative 6-month VAS
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Effectiveness of Vitamin D3 supplementation in migraine prophylaxis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: weight-bearing MME values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: ΔMME values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Percentage of children correctly choosing the healthiest or unhealthiest option
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Binge eating frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Primary-end-point events
Endpoint domain: Mortality/survival
Primary endpoint: Progression of tricuspid regurgitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: median survival benefits
Endpoint domain: Mortality/survival
Primary endpoint: cumulative risk of stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: late risk of re-interventions
Endpoint domain: Adverse events/effects
Primary endpoint: Preference for active surveillance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement of MMO
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: skin homogeneity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: spots length
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: wrinkles area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Rate of positive results in retest (RT+)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: workplace productivity
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Mean area under the ROC curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Global health status/quality of life (GHS/QOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Symptom burden
Endpoint domain: Adverse events/effects
Primary endpoint: GA lesion progression rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Phase I Time reductions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxygen supplementation requirements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alertness ratings
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Mean sleep latency on MWT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in weekly rate of cataplexy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of outliers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concordance between tool and genetic counselor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: UPDRS‐III scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Leg microvascular function (LMVF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Immediate success rate of PCI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: MACE within 24 months after the operation
Endpoint domain: Adverse events/effects
Primary endpoint: mean eIELT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean NITBE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-evaluation of improvement (CGIC≥1)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: mean decrease in HRSD score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in days of limitation
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Improvement in skin moisturization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: α-diversity of fecal microbiome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of Bifidobacterium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of butyric acid and other metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: neonatal RCV as a percentage of fetoplacental volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: carotid flow fluctuations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Drug exposure at steady state (AUCτ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence rate of withdrawal syndrome
Endpoint domain: Adverse events/effects
Primary endpoint: dosage reduction rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of medical orders
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Median time to first hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: lifetime prevalence of wheezing
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: lifetime prevalence of noninfectious rhinitis
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: lifetime prevalence of hay fever
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: End-stage kidney disease (ESKD) events
Endpoint domain: Mortality/survival
Primary endpoint: Kidney function decline events
Endpoint domain: Mortality/survival
Primary endpoint: slowing tumor growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: progression-free survival
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Elimination rate of cardinal symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of physicians offering new patient appointments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Platelet count ≥30 × 10^9 /L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Response at ≥75% of assessments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total recovery time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical benefit rate (≥ 12 weeks)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: composite IC Z-scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive decline measured by 3MSE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Deaths during admission
Endpoint domain: Mortality/survival
Primary endpoint: RBANS language score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resolution of damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aspirin use
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Smoking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptance of topic suggestions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Health-Related Quality of Life (HRQOL) total score in children
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Health-Related Quality of Life (HRQOL) social domain in adults
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Health-Related Quality of Life (HRQOL) physical domain in girls
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Indexed end diastolic volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Indexed end systolic volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Perceptions of Preventable Adverse Events
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Weight reduction ≥5%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of developing DM in LMS patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasma levels of dicarbonyls (methylglyoxal, glyoxal, 3-deoxyglucosone)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: plasma free AGEs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: plasma d-lactate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: RMS_T change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: elastin gene expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes